Seropositivity against HPV 16 capsids: A better marker of past sexual behaviour than presence of HPV DNA

Genitourinary Medicine

Volumn 73, Issue 2, 1997, Pages 131-135

  Olsen, Anne O ^a   Dillner, Joakim ^a   Gjøen, Kirsti ^a   Magnus, Per ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Capsids; DNA; Human papilloma virus; Sexual behaviour

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEXUAL BEHAVIOR; VIRUS CAPSID; VIRUS INFECTION; WART VIRUS;

EID: 79960396372     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.73.2.131     Document Type: Article

References (40)

1. Eluf Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994;69:114-9.
2. Bosch FX, Munoz N, de Sanjose S, Navarro C, Moreo P, Ascunce N, et al. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993;2:415-22.
3. Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillo-mavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992;52:743-9.
4. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
5. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
6. Olsen AO, Gjoen K, Sauer T, Orstavik I, Naess O, Kierulf K, et al. Human papillomavirus and cervical intraepithelial neoplasia grade II-III: a population-based case-control study. Int J Cancer 1995;61:312-5.
7. Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, et al. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 1991;49:6-13.
8. Becker TM, Wheeler CM, McGough NS, Parmenter CA, Jordan SW, Stidley CA, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 1994;271:1181-8.
9. Jenison SA, Yu XP, Valentine JM, Koutsky LA, Christiansen AE, Beckmann AM, et al. Evidence of prevalent genital-type human papillomavirus infections in adults and children. J Infect Dis 1990;162:60-9.
10. Jochmus Kudielka I, Schneider A, Braun R, Kimmig R, Koldovsky U, Schneweis KE, et al. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 1989;81:1698-704.
11. Reeves WC, Brinton LA, Garcia M, Brenes MM, Herrero R, Gaitan E, et al. Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 1989;320:1437-41.
12. Kiviat NB, Koutsky LA, Paavonen JA, Galloway DA, Critchlow CW, Beckmann AM, et al. Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis 1989;159:293-302.
13. Kjaer SK, Engholm G, Teisen C, Haugaard BJ, Lynge E, Christensen RB, et al. Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: a population-based study. Am J Epidemiol 1990;131:669-82.
14. Villa LL, Franco EL. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J Natl Cancer Inst 1989;81:332-40.
15. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993;20:274-8.
16. Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991;83:997-1003.
17. Moscicki AB, Palefsky J, Gonzales J, Schoolnik GK. Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors. Pediatr Res 1990;28:507-13.
18. Karlsson R, Jonsson M, Edlund K, Evander M, Gustavsson A, Boden E, et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 1995;22:119-27.
19. Evander M, Edlund K, Gustavsson A, Jonsson M, Karlsson R, Rylander E, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Infect Dis 1995;171:1026-30.
20. Hildesheim A, Schiffinan MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
21. Williamson AL, Rybicki EP. Detection of genital human papillomaviruses by polymerase chain reaction amplification with degenerate nested primers. J Med Virol 1991;33:165-71.
22. Gjoen K, Siebke JC, Flikke M, Hager R, Ertzeid G, Halsos A, et al. Genital human papilloma virus infection in Oslo studied by dot blot DNA hybridization and the polymerase chain reaction. J Med Virol 1994:159-64.
23. Dillner J, Lenner P, Lehtinen M, Eklund C, Heino P, Wiklund F, et al. A population-based seroepidemiological study of cervical cancer. Cancer Res 1994:134-41.
24. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1996:494-9.
25. Dean AG, Dean JA, Burton AH, Dicker RC. Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta, Georgia, USA: Centers for Disease Control and Prevention; 1994.
26. Norusis MJ. SPSS for windows: Advanced Statistics. 6.0. Chicago, USA: SPSS INC. 1993.
27. Andersson-Ellstrom A, Dillner J, Hagmar B, Schiller J, Forssman L. No serological evidence for non-sexual spread of HPV16 [letter]. Lancet 19944:1435.
28. Andersson-Ellstrom A, Dillner J, Hagmar B, Schiller J, Sapp M, Forssman L, et al. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex Transm Dis 1993:234-8.
29. Rylander E, Ruusuvaara L, Almstromer MW, Evander M, Wadell G. The absence of vaginal human papillomavirus 16 DNA in women who have not experienced sexual intercourse. Obstet Gynecol 1993:735-7.
30. Fairley CK, Chen S, Tabrizi SN, Leeton K, Quinn MA, Garland SM. The absence of genital human papillomavirus DNA in virginal women. Int J STD AIDS 199:414-7.
31. Pao CC, Tsai PL, Chang YL, Hsieh TT, Jin JY. Possible non-sexual transmission of genital human papillomavirus infections in young women. Eur J Clin Microbiol Infect Dis 1992:221-2.
32. Dillner J, Kallings I, Brihmer C, Sikstrøm B, Koskela P, Lehtinen M, et al. Seropositivity to human papilloma-virus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis 19973:1394-8.
33. Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, et al. Determinants of genital human papillomavirus infection in low-income women in Washington, DC. Sex Transm Dis 1990:279-85.
34. Dillner J. Serology of human papillomavirus. Cancer Journal 199:264-9.
35. Dillner J. Antibody responses to denned HPV epitopes in cervical neoplasia. Papillomavirus Report 199:35-41.
36. Wikstrom A, van Doornum GJ, Quint WG, Schiller JT, Dillner J. Identification of human papillomavirus sero-conversions. J Gen Virol 1996:529-39.
37. Wideroff L, Schiffman MH, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, et al. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis 19972:1425-30.
38. Olsen AO, Dillner J, Gjoen K, Sauer T, Ørstavik I, Magnus P. A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix. Int J Cancer 1998:415-9.
39. Sun Y, Eluf Neto J, Bosch FX, Munoz N, Booth M, Walboomers JM, et al. Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil. Cancer Epidemiol Biomarkers Prev 199:341-7.
40. Mann VM, de Lao SL, Brenes M, Brinton LA, Rawls JA, Green M, et al. Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Res 1990:7815-9.